StubHub Deadline: STUB Investors Have Opportunity to Lead StubHub Holdings, Inc. Securities Lawsuit

Hyun Woo Kim, President and CEO of the Seoul Business Agency: "The Global Innovation Forum, bringing together startup ecosystem leaders from...

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

Beam Therapeutics Sets Strategic Priorities for its Genetic Disease and Hematology Franchises to Drive Execution of Late-Stage Clinical...

Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones

HealthEx Partners with Anthropic to Turn Patients’ Scattered Medical Records into Actionable Health Insights

Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance

Bitget Listed Lowest Trading Fees Across Major Crypto Exchanges

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Allegiant and Sun Country Airlines to Combine, Creating a Leading, More Competitive Leisure-Focused U.S. Airline

MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference

Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results

Visual AI Takes Center Stage at CES 2026: FIRSTHABIT’s ‘Chalk 4.0’ Becomes the Silicon Valley of Eureka Park

Rich Sparkle Holdings Closes Acquisition of TikTok Icon Khaby Lame's Core Company

Exagen Inc. Announces Select Preliminary 2025 Financial Results

REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program

Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference

LV Capital Joins Forces with LV Epoch: A Traditional Financial Powerhouse and a DeFi Innovator Usher in a New Era of On-Chain Wealth...

SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit